Outcomes of eyes with retinal vein occlusion that are lost to follow-up after antivascular endothelial growth factor therapy.
Mirataollah SalabatiRaziyeh MahmoudzadehJae-Chiang WongDillan PatelSamir N PatelAnthony ObeidArunan SivalingamJames F VanderSunir J GargAllen C HoCarl D RegilloJason HsuPublished in: The British journal of ophthalmology (2021)
RVO patients receiving anti-VEGF injections who were LTFU experienced a decline in VA that did not return to the levels seen before LTFU despite improvement in CFT after restarting therapy, underscoring the importance of ongoing treatment.